COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF TABLET RUBYCLIN AND TABLET TAKZEMA IN THE MANAGEMENT OF VICHARCHIKA W.S.R.TO ECZEMA

Authors

  • Kulkarni Eknath Ganesh Associate Professor, PG Deptt. Of Kayachikitsa, A.S.S. Ayurved Mahavidyalaya Arogyashala Rugnalaya, Panchavati, Nashik 422003, Maharashtra, India.
  • Deshmukh Babasaheb Rangarao P.G. Scholar, PG Deptt of Kayachikitsa, A.S.S. Ayurved Mahavidyalaya Arogyashala Rugnalaya, Panchavati, Nashik-422003, Maharashtra, India.
  • Pal Sunil Hariram P.G. Scholar, PG Deptt Of Kayachikitsa, A.S.S. Ayurved Mahavidyalaya Arogyashala Rugnalaya, Panchavati, Nashik-422003, Maharashtra, India
  • Kulkarni Rajan Balwant H.O.D Kayachikitsa, A.S.S. Ayurved Mahavidyalaya Arogyashala Rugnalaya, Panchavati, Nashik- 422003, Maharashtra, India.

Keywords:

Vicharchika, Eczema, Atopic Dermatitis, Ayurveda, Rubyclin, Takzema

Abstract

Vicharchika is a type of Kshudrakustha a skin disease which is characterized by symptoms namely, kandu (itching), pidaka (eruption), vaivarnya (depigmentation) and srava (discharge). Vicharchika is often correlated to eczema based on the clinical presentations. Eczematous diseases mark more than 10% of the general population and 15-25% of all dermatological patients suffer from eczema. While a large number of drugs are used for treating eczema, but there is either no scientific evidence to support their use or they have undesirable side effects. Therefore, there is a need to provide treatment options that are safe and effective. Now-a-days, many Ayurvedic companies are manufacturing many new medicines based on classical Ayurvedic texts. So, there is a need of validation of these new medicines for the use of all Ayurvedic practitioners in day to day practice. Tablet Rubyclin is such a new medicine manufactured by GMP certified Ayurvedic Company. Hence, the present study was carried out with an objective to compare the efficacy of Tablet Rubyclin with that of Tablet Takzema in Vicharchika. Study Design: The study was Single Blind Comparative Study conducted on 60 patients of Vicharchika of either sex. Patients were randomly recruited to trial group and standard group of 30 each. The trial group patients were advised Tablet Rubyclin and the controlled group were prescribed Tablet Takzema, 2 Tablet twice in a day after meal same for both groups for 30 days.

Results: From the Clinical study we had concluded that, according to the EASI severity score Tablet Rubyclin is better than Tablet Takzema in relieving signs and symptoms like Kandu (itching), Redness and scratching. As for the parameters like Kandu (itching), Pidaka (eruption), Vaivarnya (depigmentation), Srava (discharge) both Tablet Rubyclin and Tablet Takzema shows equally effective in the management of Vicharchika w.s.r.t Eczema. The Tablet Rubyclin and Tablet Takzema are equally effective in the management of Vicharchika w.s.r. to Eczema.

Downloads

Download data is not yet available.

Published

15-01-2021

How to Cite

Kulkarni Eknath Ganesh, Deshmukh Babasaheb Rangarao, Pal Sunil Hariram, & Kulkarni Rajan Balwant. (2021). COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF TABLET RUBYCLIN AND TABLET TAKZEMA IN THE MANAGEMENT OF VICHARCHIKA W.S.R.TO ECZEMA. International Journal of Applied Ayurved Research, 4(11), 1214–1226. Retrieved from https://ijaar.in/index.php/journal/article/view/935

Issue

Section

Research Articles